CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262540421
- Phone
- 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 37,142 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 25 Other Notification of Removal from Listing
- CERT Other Certification
- 8-A12B Other Registration of Securities
- 8-K Event Delisting notice · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 4 Open-market buy Director bought 181 shares at $27.66 ($5,006)
- 4 Open-market buy Director bought 5,000 shares at $27.40 ($137,000)
- 4 Open-market buy PRESIDENT AND CEO bought 18,000 shares at $27.61 ($496,980)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 500 shares at $37.61 ($18,805)
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
Page 11 of 16 · 315 filings